Document text
Principal Investigator: TERRY L. SHEPPARD
Organization: KEYSTONE SYMPOSIA
Fiscal Year: 2023
Award: $6,000
Funding agency: National Cancer Institute
ABSTRACT
Support is requested for a Keystone Symposia conference entitled B Cells and Tertiary Lymphoid Structures:
Emerging Targets in Cancer Therapeutics, organized by Drs. Tullia Bruno, Brad Nelson, Daniel Hollern and
Marie-Caroline Dieu-Nosjean. The conference will be held in Whistler, British Columbia from October 1-4, 2023.
With vaccines, antibody-based immunotherapy, and scientific discoveries of B cell functional mechanisms, major
breakthroughs are happening surrounding B cells. This marks a field of research that is poised for exponential
growth in acquisition of knowledge and effective therapies. In particular, the novel insights into B cell biology
have revealed conserved aspects across disease; for example, B cells are now recognized as critical players in
Tertiary Lymphoid Structures (TLS) for both cancer patient response to immunotherapy and the severity of
autoimmune disease. Likewise, B regulatory cells use mechanisms to protect from autoimmunity that are
common to the mode by which they fuel cancer’s progression and resistance to therapy. By examining data
across disciplines, scientists are gleaning major insights that shape the forward progression of the entire field of
research. To foster the process of breakthroughs in the field of B cell research, we have established the B Cells
in Cancer Consortium (BC3) to bring together this ever-growing community, and as expected, there is high
interest. Specifically, our first year has built a constituency of more than 500 scientists for our virtual seminar
series. This signifies a likelihood for an even larger audience given the expansive pace of immunology research
driven by the global pandemic. With mRNA vaccines and monoclonal antibody therapies being a topic of high
exposure, people are more informed than ever on B cell biology. This inaugural Keystone Symposia conference
will be the first opportunity for this nascent field to meet together, providing a unique opportunity to forge new
connections and catalyze future research into the importance of B cell function in cancer.
Terms: <Address><Antibodies><Antibody Response><Autoantigens><Autoimmune Diseases><Autoimmune Status><Autoimmunity><Autologous Antigens><B blood cells><B cell><B cells><B-Cell Subsets><B-Cells><B-Lymphocyte Subsets><B-Lymphocytes><B-cell><British Columbia><Cancer Burden><Cancer Patient><Cancers><Career Choice><Career Path><Cell Body><Cell Function><Cell Process><Cell physiology><Cells><Cellular Function><Cellular Physiology><Cellular Process><Cellular biology><Clinical><Collaborations><Communities><Data><Discipline><Disease><Disorder><Economic Burden><Ectopic lymphoid organ><Ectopic lymphoid structure><Educational workshop><Emotional><Fostering><Future><Generalized Growth><Glean><Goals><Growth><Immune mediated therapy><Immune response><Immunological response><Immunologically Directed Therapy><Immunology><Immunotherapy><Industry><Investigators><Knowledge><Knowledge acquisition><Learning><Malignant Neoplasms><Malignant Tumor><Methodology><Monoclonal Antibody Therapy><National Cancer Burden><Outcome><Participant><Patients><Persons><Process><RNA vaccine><RNA-based vaccine><Research><Research Personnel><Researchers><Role><Scientist><Self-Antigens><Series><Severities><Shapes><Societies><Subcellular Process><Technology><Tertiary lymphoid structure><Therapeutic><Tissue Growth><Vaccines><Work><Workshop><anti-cancer immunotherapy><anticancer immunotherapy><autoimmune condition><autoimmune disorder><autoimmunity disease><cancer immunotherapy><cancer progression><career><career aspiration><career interest><career pathway><career track><cell biology><clinical practice><clinical translation><clinically translatable><combat><conference><convention><effective therapy><effective treatment><forging><host response><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunoresponse><immunotherapy for cancer><immunotherapy of cancer><improved><insight><interest><mAB-based therapy><mAb therapy><mAb-based therapeutics><mRNA vaccine><mRNA-based vaccine><malignancy><meeting><meetings><member><multidisciplinary><neoplasm progression><neoplasm/cancer><neoplastic progression><novel><ontogeny><pandemic><pandemic disease><patient response><patient specific response><posters><resistance to therapy><resistant to therapy><response><responsive patient><social role><summit><symposia><symposium><tertiary lymphoid organ><therapeutic resistance><therapy resistant><training opportunity><treatment resistance><tumor><tumor progression><vaccine antibodies><vaccine induced antibodies><vaccine-induced antibodies><virtual>